- Home
- TYGO vs ANIX Comparison
TYGO vs ANIX Comparison
Compare TYGO & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- ANIX
- Stock Information
- Founded
- TYGO 2007
- ANIX 1982
- Country
- TYGO United States
- ANIX United States
- Employees
- TYGO N/A
- ANIX N/A
- Industry
- TYGO Semiconductors
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- TYGO Technology
- ANIX Health Care
- Exchange
- TYGO Nasdaq
- ANIX Nasdaq
- Market Cap
- TYGO 116.0M
- ANIX 95.7M
- IPO Year
- TYGO N/A
- ANIX 1987
- Fundamental
- Price
- TYGO $2.50
- ANIX $4.33
- Analyst Decision
- TYGO Strong Buy
- ANIX Strong Buy
- Analyst Count
- TYGO 1
- ANIX 3
- Target Price
- TYGO $6.00
- ANIX $9.00
- AVG Volume (30 Days)
- TYGO 761.5K
- ANIX 272.8K
- Earning Date
- TYGO 11-05-2025
- ANIX 09-10-2025
- Dividend Yield
- TYGO N/A
- ANIX N/A
- EPS Growth
- TYGO N/A
- ANIX N/A
- EPS
- TYGO N/A
- ANIX N/A
- Revenue
- TYGO $74,405,000.00
- ANIX N/A
- Revenue This Year
- TYGO $94.76
- ANIX N/A
- Revenue Next Year
- TYGO $23.23
- ANIX N/A
- P/E Ratio
- TYGO N/A
- ANIX N/A
- Revenue Growth
- TYGO 52.31
- ANIX N/A
- 52 Week Low
- TYGO $0.58
- ANIX $2.07
- 52 Week High
- TYGO $2.95
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- TYGO 62.62
- ANIX 63.20
- Support Level
- TYGO $2.34
- ANIX $4.00
- Resistance Level
- TYGO $2.95
- ANIX $4.98
- Average True Range (ATR)
- TYGO 0.20
- ANIX 0.30
- MACD
- TYGO -0.03
- ANIX 0.10
- Stochastic Oscillator
- TYGO 37.00
- ANIX 61.67
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.